XOM: FY25 Deep Dive
Production hit 4.74 MBOEPD — first full year with Pioneer at +9.3% YoY. Upstream earned $21.4B but lower price realizations cut net income to $28.8B (−14%). $37.5B returned to shareholders.
Key Takeaways
ExxonMobil closed fiscal 2025 (calendar year ended December 31, 2025) at $323.9 billion of total revenue, down 4.5% year-over-year on lower average crude and refined product realizations. Production volumes told the offsetting story — oil-equivalent production reached 4,736 thousand BOE per day, a 9.3% YoY increase reflecting the first full year of Pioneer Natural Resources integration (closed May 2024) plus continued Guyana ramp. Net income attributable to ExxonMobil came in at $28.8 billion (down 14% on the price-deck weakness), with Upstream contributing $21.4 billion (74% of segment earnings), Energy Products (downstream refining + fuels) $7.4 billion, Specialty Products $2.9 billion, and Chemical Products only $0.8 billion (the weakest chemicals year in over a decade reflecting global capacity oversupply). Operating cash flow was $52.0 billion, capex stepped up to $28.4 billion, and free cash flow held at $23.6 billion — funding $37.5 billion of capital return ($20.3B buybacks + $17.2B dividends, with the dividend per share raised to $4.00 from $3.84). Sell-side coverage is 15 analysts: 8 Buy / 7 Hold / 0 Sell, consensus PT $170, range $151-$185.
Main business structure
Four reporting segments since the 2024 reorganization:
| Segment | FY25 Earnings ($M) | % of Total Earnings | US ($M) | Non-US ($M) |
|---|---|---|---|---|
| Upstream | 21,354 | 65.6% | 5,063 | 16,291 |
| Energy Products | 7,423 | 22.8% | 2,992 | 4,431 |
| Specialty Products | 2,857 | 8.8% | 1,200 | 1,657 |
| Chemical Products | 800 | 2.5% | 903 | (103) |
| Corporate / financing (net) | (3,590) | — | — | — |
| Total Net Income (attributable) | 28,844 | 100% |
Upstream is the dominant earnings engine — oil & gas exploration and production globally. Pioneer integration added ~750 thousand BOE/day to the production base; Guyana production (Stabroek block, operated by ExxonMobil) crossed 700K BOE/day across the floating production / storage / offloading vessels (Liza Destiny, Liza Unity, Prosperity, ONE Guyana). Permian + Guyana together represent the majority of US upstream earnings.
Energy Products is the refining and fuels business — global refining footprint, lubricants base oils, fuels marketing. FY25 refining margins compressed from FY24 highs as global product cracks normalized.
Specialty Products houses lubricants (Mobil 1 brand), basestocks, synthetics, and waxes. Higher-margin downstream products with less commodity-price sensitivity.
Chemical Products is the petrochemicals business — polyethylene, polypropylene, intermediates. The $800M earnings number is the weakest in over a decade and reflects global ethylene oversupply — the segment is at trough margins waiting on capacity rationalization.
Geographic mix. Upstream is roughly 75% non-US (Guyana, Permian-equivalent international assets, LNG). Downstream is more US-weighted in Energy Products and Specialty Products. Chemical Products skews international but is the smallest segment.
Customer concentration. As a commodities-product producer selling to wholesalers, refiners, petrochemical customers, and direct retail (ExxonMobil-branded fuel), no single customer concentration is disclosed.
Scale anchors. Production 4,736K BOE/day. Refining capacity ~4.5 million barrels/day across 22 refineries. ~16,000 ExxonMobil-branded retail sites globally. Permian Basin position: ~1.6 million net acres post-Pioneer.
Key core metrics (3-year trend)
1. Oil-equivalent production
| FY23 | FY24 | FY25 | |
|---|---|---|---|
| Production (K BOE/d) | 3,737 | 4,333 | 4,736 |
| YoY | — | +16% | +9.3% |
FY24's +16% jump was the partial-year Pioneer integration; FY25's +9.3% is the first clean post-integration year plus continued Guyana ramp. The production trajectory is the structurally strongest in the major-IOC peer group.
2. Net income trajectory
| FY23 | FY24 | FY25 | |
|---|---|---|---|
| Net income ($B) | 36.0 | 33.7 | 28.8 |
| YoY | — | -6% | -14% |
Two consecutive years of net income decline — the price-deck weakness more than offset the production growth and Pioneer synergies. Net income on a per-BOE basis: ~$26 FY23 → $21 FY24 → $17 FY25.
3. Capital allocation (buybacks vs dividends)
| FY23 | FY24 | FY25 | |
|---|---|---|---|
| Dividends ($B) | 14.9 | 16.7 | 17.2 |
| Buybacks ($B) | 17.4 | 19.6 | 20.3 |
| Total return ($B) | 32.3 | 36.3 | 37.5 |
Capital return has grown each year despite the earnings decline — the company funded the buyback program through balance sheet draw-down (cash position fell from $23.2B to $10.7B in FY25). Dividend per share raised to $4.00 (from $3.84), maintaining XOM's 40+ year track record of consecutive annual dividend increases.
4. Free cash flow trajectory
| FY23 | FY24 | FY25 | |
|---|---|---|---|
| OCF ($B) | 55.4 | 55.0 | 52.0 |
| Capex ($B) | 26.3 | 24.3 | 28.4 |
| FCF ($B) | 29.1 | 30.7 | 23.6 |
FY25 FCF compressed $7B as capex stepped up and OCF declined modestly. Total capital return of $37.5B exceeded FCF of $23.6B by $14B — the gap funded by cash drawdown and modest debt paydown ($36.8B → $34.2B long-term debt).
Market evaluation
Sell-side coverage (as of April 27, 2026). 15 analysts cover the stock.
| Rating | Count |
|---|---|
| Buy / Outperform / Overweight | 8 |
| Hold / Peer Perform | 7 |
| Sell | 0 |
Price targets. Consensus $170.07, range $151 (low) to $185 (high: Wells Fargo).
Recent analyst activity (Feb 26 through April 27, 2026). All 19 covered actions carried importance-5; the action set was unusually heavy on rating changes for a mega-cap energy name.
Two rating changes in opposite directions, both on April 17-21:
- Wolfe Research (Doug Leggate) — downgraded Outperform → Peer Perform on April 21 (no PT issued, citing valuation following YTD outperformance)
- BNP Paribas (Lucas Herrmann) — upgraded Underperform → Neutral on April 17 with PT $125 → $165 (+$40, the largest single PT raise in the window)
PT moves clustered post-Q4 FY25 earnings and recent Q1 FY26 reads:
- Scotiabank: $128 → $163 (+$35) on April 22, Sector Outperform maintained
- JP Morgan: $140 → $170 (+$30) on April 9
- Wells Fargo (Sam Margolin): $183 → $185 on April 9 — highest PT in the group
The Buy / Hold split (8 / 7) reflects a bifurcation between analysts emphasizing the production-growth thesis (Pioneer + Guyana) and analysts emphasizing earnings sensitivity to crude / chemicals price cycles.
Buy-side positioning. XOM is a core large-cap energy holding. Less crowded than the AI-tech mega-caps; modestly under-owned among ESG-constrained mandates. Short interest below 1% of float.
FY25 corporate structure: production growth absorbing price cycles
FY25 is the year ExxonMobil's production growth thesis carried weight against an unfavorable price deck. Production +9.3% on the first full year of Pioneer integration plus Guyana ramp is structurally the fastest growth in the major IOC group — Chevron, Shell, BP, TotalEnergies, Eni all in low-single-digit ranges. The trade-off visible in FY25: net income fell 14% despite the volume growth because crude realizations and chemical margins both compressed simultaneously. The two open structural questions into FY26: (a) when chemical margins recover from the current trough — Chemical Products at $800M earnings vs ~$3B in mid-cycle years means ~$2B of latent earnings power is on hold pending capacity rationalization; (b) whether Guyana production can continue stepping up at the FY24-FY25 pace as the Whiptail and Stabroek follow-on developments come online. The Q1 FY26 print this week is the first read on both questions.